Noxopharm Financials
We recommend to make use of Noxopharm Limited fundamental analysis to find out if markets are presently mispricing the entity. Strictly speaking this technique allows you to check out available financial ratios of Noxopharm Limited as well as the relationship between them. We were able to break down and interpolate data for twenty-seven available fundamentals for Noxopharm, which can be compared to its peers in the industry.
Noxopharm |
Understanding current and past Noxopharm Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Noxopharm's financial statements are interrelated, with each one affecting the others. For example, an increase in Noxopharm's assets may result in an increase in income on the income statement.
The data published in Noxopharm's official financial statements usually reflect Noxopharm's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Noxopharm Limited. For example, before you start analyzing numbers published by Noxopharm accountants, it's critical to develop an understanding of what Noxopharm's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Noxopharm's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Noxopharm's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Noxopharm's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Noxopharm Limited. Please utilize our Beneish M Score to check the likelihood of Noxopharm's management manipulating its earnings.
Noxopharm Stock Summary
Noxopharm competes with ZyVersa Therapeutics, Palisade Bio, Unicycive Therapeutics, Immix Biopharma, and Tscan Therapeutics. Noxopharm Limited, a drug development company, focuses on developing treatment options for a range of solid tumor cancers and septic shock in Australia and internationally. The company was incorporated in 2015 and is based in Chatswood, Australia. Noxopharm operates under Biotechnology classification in the United States and is traded on OTC Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | Tower A, The |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | NYSE Composite |
| Website | www.noxopharm.com |
| Phone | 61 2 9144 2223 |
| Currency | USD - US Dollar |
You should never invest in Noxopharm without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Noxopharm Pink Sheet, because this is throwing your money away. Analyzing the key information contained in Noxopharm's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Noxopharm Key Financial Ratios
Generally speaking, Noxopharm's financial ratios allow both analysts and investors to convert raw data from Noxopharm's financial statements into concise, actionable information that can be used to evaluate the performance of Noxopharm over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Noxopharm Limited reports annually and quarterly.| Return On Equity | -0.58 | |||
| Return On Asset | -0.16 | |||
| Beta | 1.25 |
Noxopharm Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Noxopharm's current stock value. Our valuation model uses many indicators to compare Noxopharm value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Noxopharm competition to find correlations between indicators driving Noxopharm's intrinsic value. More Info.Noxopharm Limited is considered to be number one stock in return on equity category among related companies. It is considered to be number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Noxopharm by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Noxopharm's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Noxopharm's earnings, one of the primary drivers of an investment's value.Noxopharm Limited Systematic Risk
Noxopharm's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Noxopharm volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Noxopharm Limited correlated with the market. If Beta is less than 0 Noxopharm generally moves in the opposite direction as compared to the market. If Noxopharm Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Noxopharm Limited is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Noxopharm is generally in the same direction as the market. If Beta > 1 Noxopharm moves generally in the same direction as, but more than the movement of the benchmark.
About Noxopharm Financials
What exactly are Noxopharm Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Noxopharm's income statement, its balance sheet, and the statement of cash flows. Potential Noxopharm investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Noxopharm investors may use each financial statement separately, they are all related. The changes in Noxopharm's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Noxopharm's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Noxopharm Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Noxopharm is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Noxopharm has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Noxopharm's financials are consistent with your investment objective using the following steps:- Review Noxopharm's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Noxopharm's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Noxopharm's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Noxopharm's stock is overvalued or undervalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Noxopharm Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Noxopharm Pink Sheet analysis
When running Noxopharm's price analysis, check to measure Noxopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Noxopharm is operating at the current time. Most of Noxopharm's value examination focuses on studying past and present price action to predict the probability of Noxopharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Noxopharm's price. Additionally, you may evaluate how the addition of Noxopharm to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |